United States Últimas notícias

Private schools in the US are increasing financial aid and advertising discounts to attract students, as soaring tuition and a declining population of school-age children intensify competition. Some schools, such as Brearley and Deerfield Academy, are offering free tuition to families earning under certain income thresholds, and using sliding scales to determine tuition for higher-earning families. Bloomberg's Erin Hudson joins Bloomberg's Intelligence to discuss.

Stanley Druckenmiller, the billionaire investor who mentored US Treasury Secretary Scott Bessent in his early career as a hedge fund trader, suggested his former pupil is making a mistake by wading into the bond market. Bessent has recently pledged to increase the Treasury's purchases of long-dated bonds, a move widely seen as an attempt to push down yields in the world's most important debt market. Jason Trennert, Chairman and CEO at Strategas Research Partners, discusses US Treasury Secretary Scott Bessent's focus on yields and what to expect from Jackson Hole and the Fed.

Huntsman (NYSE:HUN) and Olin (NYSE:OLN) announced that shareholders of both companies approved proposals required to complete their all-stock merger of equals, which will create OlinHuntsman Corporation.

On this episode of Stock Movers: - Dick's Sporting Goods (DKS) shares are plummeting as it lowered its full-year outlook amid weakness at its recently acquired Foot Locker unit. - Apple (AAPL) shares are slightly lower as the tech giant is gearing up to launch a new version of its Mac mini desktop computer for the first time in almost two years, according to people familiar with the matter. - SpaceX (SPCX) shares are higher in the premarket as Elon Musk says SpaceX's first AI satellites, powered by Nvidia chips, will initially launch in the fourth quarter of next year and hit "significant scale" in 2028.

BeOne Medicines (NASDAQ:ONC) received U.S. FDA approval for TEVIMBRA (tislelizumab) combined with ZIIHERA (zanidatamab) and chemotherapy as a first-line treatment for adults with unresectable locally advanced or metastatic HER2-positive gastroesophageal adenocarcinoma.

Thoma Bravo executives gave ground to lenders, resulting in 40 creditor-friendly changes to the deal documents for Proofpoint, including tighter limits on future borrowing and regular check-in calls. Sridhar Natarajan has more on "Bloomberg Open Interest."

US consumer confidence fell in August to the worst since the start of the year as the Conference Board's gauge of confidence decreased 0.8 points to 89.4 after a downward revision to the prior month. Michael McKee breaks down the data on Bloomberg Television.

Jazz Pharmaceuticals (NASDAQ:JAZZ) received U.S. Food and Drug Administration approval for two Ziihera (zanidatamab-hrii) treatment regimens for adults with unresectable locally advanced or metastatic HER2-positive gastroesophageal adenocarcinoma.

Anavex Life Sciences (NASDAQ:AVXL) reported third fiscal quarter 2026 results and provided updates on blarcamesine development programs targeting Alzheimer’s disease, Rett syndrome, and Fragile X syndrome.

Vyome Holdings (NASDAQ:HIND) reported second-quarter 2026 results and provided a corporate update, highlighting progress on VT-1953, its lead program for symptoms associated with malignant fungating wounds.

Dan Suzuki, global investment strategist at iCapital, discusses the Treasury's recent attempts to lower long-term yields, arguing that the measures taken so far are insufficient and largely symbolic. Speaking on "Bloomberg Surveillance," Suzuki also says the Federal Reserve will have to start hiking rates at some point.

Trey Parker, chief investment officer and co-founder of Sycamore Tree Capital Partners, sees opportunities in credit related to the AI boom, along with risks. He tells Bloomberg's Julie Fine that he sees parallels to the late-1990s telecom collapse and favors short maturities and strong data-center tenant ratings.